An in-depth look at the leading 3D printing stocks in the U.S stock market this year. Here’s what you need to know.
CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its proprietary, non-animal recombinant human collagen ...
In the 3D printing world, 2021 is shaping up to be the year of bioprinting, with both 3D Systems (DDD-1.62%) and Desktop Metal (DM) entering the commercial bioprinting market this year. Bioprinting ...
Advances in regenerative medicine are transforming how we approach tissue and organ repair, offering patient-specific and functional alternatives to ...
The 3D bioprinting of an ear from living tissue is no trivial achievement. Reconstruction of ears has been done before with adults, but this is a quite different bio environment, effectively creating ...
New York Tech and UC Irvine develop a 3D-printed human colon model to advance cancer drug testing and gastrointestinal ...
3D bioprinting technology has managed to accomplish something that's never been done before: depict an actual, active tumor in its entirety. The 3D bioprinter developed in Russia stands on a table ...
CTIBIOTECH™, a leading innovator in human tissue engineering and 3D bioprinting, is proud to announce its selection by SATT AxLR and CILCARE to support the development of the OrgaEar project. This ...
Recently, nanoparticle-driven 3D bioprinting has emerged as a revolutionary approach for high-throughput drug screening, offering enhanced scalability, accuracy, and efficiency while reducing reliance ...
In the 3D printing world, 2021 is shaping up to be the year of bioprinting, with both 3D Systems (NYSE: DDD) and Desktop Metal (NYSE: DM) entering the commercial bioprinting market this year.